Status:
COMPLETED
Non-Invasive Neuromodulation in Children With Neurodevelopmental Disorders
Lead Sponsor:
University of Las Palmas de Gran Canaria
Conditions:
Neurodevelopmental Disorders
Eligibility:
All Genders
2-25 years
Phase:
NA
Brief Summary
Children with neurodevelopmental disorders have a delay in acquiring the skills that are assumed considering the phases of typical psychomotor development. Added to this difficulty and main element of...
Detailed Description
While the application is being sent to the ethics committee, we will hold a series of informative talks for the centre's staff who, in one way or another, will be involved in the development of the pr...
Eligibility Criteria
Inclusion
- Sensory-motor alteration.
- Be schooled in the Center of the City San Juan de Dios of Las Palmas de Gran Canaria.
- Meet the criteria established by the Rome IV constipation scale.
- Informed consent signed by the family, guardian or legal representative.
Exclusion
- No contraindications to treatment with NXSignal: Pacemaker, internal bleeding, do not apply electrodes on skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobia to electricity.
- Epilepsia.
- Subjects who modify eating habits and/or water intake.
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 27 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT05265702
Start Date
March 7 2022
End Date
April 27 2022
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aníbal Báez Suárez
Las Palmas de Gran Canaria, Palmas, Las, Spain, 35018